Han-sol Jeong
Yangsan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Real-world evidence on the additional cancer risk reduction of ezetimibe: a 10-year nationwide retrospective cohort study emulating a target trial.
Journal: Journal of cancer research and clinical oncology
Published: April 01, 2025
Nutrient Availability Dictates Cancer Metabolism-Based Therapeutic Responses to Nononcology Drugs.
Journal: Cancer research
Published: March 12, 2025
Correction: The LKB1-TSSK1B axis controls YAP phosphorylation to regulate the Hippo-YAP pathway.
Journal: Cell death & disease
Published: November 26, 2024
Regulation of Hippo-YAP signaling axis by Isoalantolactone suppresses tumor progression in cholangiocarcinoma.
Journal: Translational oncology
Published: January 18, 2024
The LKB1-TSSK1B axis controls YAP phosphorylation to regulate the Hippo-YAP pathway.
Journal: Cell death & disease
Published: July 31, 2023
MHY4571, a novel diarylcyclohexanone derivative, exerts anti-cancer activity by regulating the PKA-cAMP-response element-binding protein pathway in squamous cell lung cancer.
Journal: Experimental hematology & oncology
Published: June 01, 2022
Phosphorylation analysis of the Hippo-YAP pathway using Phos-tag.
Journal: Journal of proteomics
Published: August 02, 2021
The ethanol extract of Garcinia subelliptica Merr. induces autophagy.
Journal: BMC complementary medicine and therapies
Published: May 09, 2021
Hesperetin inhibit EMT in TGF-β treated podocyte by regulation of mTOR pathway.
Journal: Biochemical and biophysical research communications
Published: April 16, 2020
Extracts of Perilla frutescens var. Acuta (Odash.) Kudo Leaves Have Antitumor Effects on Breast Cancer Cells by Suppressing YAP Activity.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: February 10, 2020
Last Updated: 09/26/2026